The association of cytokines with severe dengue in children

Tropical Medicine and Health

Volumn 42, Issue 4, 2014, Pages 137-144

  Mangione, Julia N A ^a,b   Huy, Nguyen Tien ^a   Lan, Nguyen Thi Phuong ^c   Mbanefo, Evaristus Chibunna ^a   Ha, Tran Thi Ngoc ^c   Bao, Lam Quoc ^a   Nga, Cao Thi Phi ^d   Van Tuong, Vo ^d   Van Dat, Tran ^d   Thuy, Tran Thi ^e   Tuan, Ha Manh ^e   Huong, Vu Thi Que ^c   Hirayama, Kenji ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PASTEUR INSTITUTE   (Viet Nam)

^d District 4 Center of Preventive Medicine   (Viet Nam)

^e Children's Hospital   (Viet Nam)

Author keywords

Association; Cytokine; Dengue; Severity; Shock

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DENGUE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOCRIT; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SECONDARY INFECTION; VIRUS ISOLATION;

EID: 84948740441     PISSN: 13488945     EISSN: 13494147     Source Type: Journal    
DOI: 10.2149/tmh.2014-09     Document Type: Article

References (44)

1. WHO. Dengue guidelines for diagnosis, treatment, prevention and control. Geneva, Switzerland: World Health Organization; 2009.
2. Halstead SB. Dengue. Lancet 2007; 370(9599): 1644–1652.
3. Wilder-Smith A, Ooi EE, Vasudevan SG, et al. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 2010; 12 (3): 157–164.
4. World Health Organization. Dengue and dengue haemorrhagic fever: diagnosis, treatment, prevention, and control. 2nd ed. Geneva, Switzerland: World Health Organization; 1997.
5. Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8(12): S7–S16.
6. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009; 22(4): 564–581.
7. Chaturvedi UC, Agarwal R, Elbishbishi EA, et al. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 2000; 28: 183–188.
8. Futura T, Murao LA, Lan NTP, et al. Association of mast cell-derived VEGF-A and Proteases in Dengue shock syndrome. PLoS Negl Trop Dis 2012; 6(2): e1505.
9. Butthep B, Chunhakan S, Yoksan S, et al. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J 2012; 31(12): e232–e238.
10. Koraka P, Murgue B, Deparis X, et al. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection. J Med Virol 2004; 72: 445–450.
11. Huy NT, Giang TV, Thuy DH, et al. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis 2013; 7(9): e2412.
12. Kinoshita H, Mathenge EG, Hung NT, et al. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic fever patient. Jpn J Infect Dis 2009; 62: 343–350.
13. Gubler DJ, Kuno G, Sather GE, et al. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984; 33: 158–165.
14. Innis BL, Nisalak A, Nimmannity S, et al. An enzymelinked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am J Trop Med Hyg 1989; 40: 418–427.
15. Lanciotti RS, Calisher CH, Gubler DJ, et al. Rapid detection and typing of the dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30: 545–551.
16. Bozza FA, Cruz OG, Zagne SM, et al. Multiplex cytokine profile for dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008; 8: 86.
17. Chen LC, Lei HY, Liu CC, et al. Correlation of serum levels of microphage migration inhibitory factor with disease severity and clinical outcome in Dengue patients. Am J Trop Med Hyg 2006; 74: 142–147.
18. Suharti C, van Gorp EC, Dolmans WM, et al. Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 2003; 14: 172–177.
19. Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Med Virol 1999; 59: 329–334.
20. Avirutnan P, Malasit P, Seliger B, et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Im- munol 1998; 161: 6338–6346.
21. Raghupathy R, Chaturvedi UC, Al-Sayer H, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 1998; 56: 280–285.
22. Huang YH, Lei HY, Liu HS, et al. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63: 71–75.
23. Bosch I, Xhaja K, Estevez L, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002; 76: 5588–5597.
24. Limonta D, Capo V, Torres G, et al. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 2007; 40: 50–54.
25. Schroder K, Hertzog PJ, Ravasi T, et al. Interferongamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163–189.
26. Braga EL, Moura P, Pinto LM, et al. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazillian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001; 96: 229–232.
27. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991; 88: 1473–1480.
28. Azeredo EL, Zagne SM, Santiago MA, et al. Characterization of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001; 204: 494–507.
29. Juffrie M, vd Meer GM, Veerman AJP, et al. Inflammatory mediators in dengue virus infection: circulating interleukin-12 and interferon-γ. Dengue Bulletin 2002; 26: 144–154.
30. Lee YR, Hung NT, Liu CC, et al. Correlation of IFNinducible protein 10 levels in sera with disease severity and clinical outcome of the dengue patients. Am J Infect Dis 2008; 4(1): 18–21.
31. Hung NT, Lei HY, Nguyen TL, et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004; 189: 221–232.
32. Chaturvedi UC, Raghupathy R, Pacsa AS, et al. Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Current Science 1999; 76(1): 65–69.
33. Soundravally R, Hoti SL, Patil SA, et al. Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. Int J Infect Dis 2014; 18: 68–72.
34. Murgue B, Cassar O, Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. J Med Virol 2001; 65: 97–104.
35. Cardier JE, Rivas B, Romano E, et al. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 2006; 13: 335–340.
36. Cardier JE, Marino E, Romano E, et al. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 2005; 30: 359–365.
37. Yen YT, Chen HC, Lin YD, et al. Enhancement by tumor necrosis factor alpha of dengue-virus induced endothelial cell production of reactive nitrogen and oxygen species is the key to hemorrhage development. J Virol 2008; 82: 1213–1224.
38. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985.
39. Leung DW, Cachianes G, Kuang WJ, et al. Vascular Endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309.
40. Tseng CS, Lo HW, Teng HC, et al. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Micriobiol 2005; 43: 99–102.
41. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 2007; 81: 1592–1600.
42. Sathupan P, Khongpattanayothin A, Srisai J, et al. The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection. Ann Trop Paediatr 2007; 27: 179–184.
43. Seet RCS, Chow AWL, Quek AML, et al. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. Int J Infect Dis 2009; 13: e248–e253.
44. Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010; 338: 67–82.